Caption Management’s Novavax NVAX Stock Holding History

Caption Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.21M	Buy	148,155 +9,105	+7%	+$82.5K	0.01%	960
2025 Q4	$934K	Buy	+139,050	New	+$1.05M	0.01%	1080
2025 Q2	–	Sell	-94,345	Closed	-$625K	–	1757
2025 Q1	$605K	Buy	+94,345	New	+$780K	0.01%	1053
2024 Q3	–	Sell	-12,000	Closed	-$155K	–	1498
2024 Q2	$152K	Sell	12,000 -9,698	-45%	-$97.6K	﹤0.01%	987
2024 Q1	$104K	Buy	+21,698	New	+$101K	﹤0.01%	1055
2021 Q2	–	Sell	-7,700	Closed	-$1.4M	–	1495
2021 Q1	$1.4M	Buy	+7,700	New	+$1.53M	0.03%	611
2019 Q1	–	Sell	-29,500	Closed	-$931K	–	687
2018 Q4	$1.08M	Buy	+29,500	New	+$1.14M	0.09%	254

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's NVAX Position: Q1 2026 in Review

Caption Management increased its Novavax (NVAX) stake by 6.5% in Q1 2026, buying an estimated $82.5K and bringing the position to 148,155 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #960.

Caption Management first reported a position in NVAX in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Caption Management held 148,155 shares of Novavax worth $1.21M as of Q1 2026.
Caption Management bought 9,105 Novavax shares in Q1 2026, an estimated $82.5K.
Novavax made up 0.01% of Caption Management's portfolio in Q1 2026, its #960 holding.
Caption Management first reported a position in Novavax in Q4 2018 and has held it in 7 quarters since.
Caption Management's Novavax position peaked at $1.4M in Q1 2021.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.